Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Wruble Clark

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rheumatology International|May 23, 2026
Neurological involvement and pregnancy outcomes in autoimmune disease: mechanisms, clinical implications, and research gapsTal Friedman Korn, Giovanna S Manzanno, Mattia Wruble Clark, et al.
Multiple Sclerosis and Related Disorders|January 23, 2026
Low prevalence of inflammatory bowel disease among patients with seropositive neuromyelitis optica spectrum disorder in two large referral centersCarolyn Akers, Philippe A Bilodeau, Mattia Wruble Clark, et al.
Frontiers in Immunology|February 11, 2026
Deep cervical lymph node analysis in central nervous system inflammatory diseaseAlexis Elena Giff, Mattia Wruble Clark, Shamik Bhattacharyya, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Multiple Sclerosis and Related Disorders|January 29, 2026
Lack of external validity of the MOG-AR score in a North American cohortMulan Jiang, Anastasia Vishnevetsky, Mattia Wruble Clark, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 6, 2026
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying TreatmentsPhilippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 6, 2026
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying TreatmentsPhilippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rheumatology International|May 23, 2026
Neurological involvement and pregnancy outcomes in autoimmune disease: mechanisms, clinical implications, and research gapsTal Friedman Korn, Giovanna S Manzanno, Mattia Wruble Clark, et al.
Multiple Sclerosis and Related Disorders|January 23, 2026
Low prevalence of inflammatory bowel disease among patients with seropositive neuromyelitis optica spectrum disorder in two large referral centersCarolyn Akers, Philippe A Bilodeau, Mattia Wruble Clark, et al.
Frontiers in Immunology|February 11, 2026
Deep cervical lymph node analysis in central nervous system inflammatory diseaseAlexis Elena Giff, Mattia Wruble Clark, Shamik Bhattacharyya, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Multiple Sclerosis and Related Disorders|January 29, 2026
Lack of external validity of the MOG-AR score in a North American cohortMulan Jiang, Anastasia Vishnevetsky, Mattia Wruble Clark, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 6, 2026
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying TreatmentsPhilippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 6, 2026
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying TreatmentsPhilippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, et al.
Pageof 1